アトラグループ revised upward its consolidated full-year earnings forecast for the fiscal year ending December 2026, with operating profit expected to exceed twice the previous fiscal year's actual result. Revenue was raised to ¥3.0 billion, ordinary profit to ¥315 million and net income attributable to owners of the parent to ¥180 million.
アトラグループ revised its consolidated full-year earnings forecast for the fiscal year ending December 2026, raising revenue from the previous forecast of ¥2.7 billion to ¥3.0 billion and operating profit from ¥160 million to ¥300 million. Ordinary profit was revised upward from ¥165 million to ¥315 million, and net income attributable to owners of the parent from ¥15 million to ¥180 million. All are expected to exceed the previous fiscal year's actual results.
The A-COMS business has remained strong through the cumulative third quarter, with revenue of ¥2.051 billion, up 18.3% year on year, segment profit of ¥257 million, up 105.8%, and consolidated operating profit of ¥251 million, up 182.9%. This has driven performance above the previous forecast and underpinned the upward revision.
Against a backdrop of growing demand for self-pay treatment, sales of the proprietary AI device “アトラゲージ” and other original equipment and consumables remained firm. Going forward, the company plans to expand its healthcare business and deepen its operations in the medical and nursing care fields, using the A-COMS platform, which has been deployed at approximately 3,000 clinics, as its foundation.
The company is restructuring its business portfolio and working to establish a structure that generates stable profits from its core business.